| | Business Summary | | Senetek
PLC
is
a
science-driven
biotechnology
company
that
develops,
manufactures
and
markets
proprietary
products
for
the
enhancement
of
quality
of
life.
The
Company
focuses
on
two
therapeutic
categories,
sexual
dysfunction
and
anti-aging.
In
connection
with
product
development
activities,
the
Company
sponsors
research
in
the
life
sciences
and
biotechnology
fields.
As
of
December
31,
2000,
the
Company
had
two
wholly
owned
subsidiaries,
Senetek
Drug
Delivery
Technologies
Inc.
and
Carme
Cosmeceutical
Sciences
Inc.
In
addition,
in
March
2001,
the
Company
formed
a
new
subsidiary
based
in
Hong
Kong. | | More
from
Market Guide: Expanded
Business Description |
| | Financial Summary | | Senetek
PLC
is
engaged
in
the
development
of
products
for
dermatological
therapeutics
and
the
treatment
of
sexual
dysfunction.
The
Company
focuses
on
biopharmaceuticals
and
proprietary
skincare
technologies.
For
the
six
months
ended
6/30/01,
revenues
totaled
$4.2
million,
up
from
$1.8
million.
Net
loss
decreased
84%
to
$505
thousand.
Revenues
reflect
increased
Kinetin
sales
and
royalties
income
from
ICN.
Lower
loss
reflects
higher
margins
and
lower
R&D
costs. | | More
from
Market Guide: Significant
Developments |
| | | | FY2000 Pay | |
| Frank Massino, 53
Chairman
and CEO | $327K | Stewart Slade
CFO,
VP - European Operations, Sec. | 117K | | Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors:
Expanded
List, Bios,
Compensation,
Options
|
|
![[one-year price graph]](http://chart.yahoo.com/c/0b/s/sntky.gif)